2020-11-16T10:48:32-06:00 2019-12-31 521853933 JONES MARESCA & MCQUADE PA 10500 LITTLE PATUXENT PARKWAY SUITE 770 COLUMBIA MD 21044 990 2019-01-01 522320756 ACCELERATE BRAIN CANCER CURE INC ACCE 2024193140 1717 RHODE ISLAND AVENUE NW NO 7 WASHINGTON DC 20036 MAX WALLACE PRESIDENT AND CEO 2024193140 2020-11-16 1 DAVID JONES P01361002 4108840220 64.88.174.3 2020-11-16 07:21:01 ES P 8135A10533E138772E75B7028466B6AE3A842BF5 25472CDEC520E8445491B9581FEBCD7C9E65366B 2019 2021-01-29 14:40:06Z X MAX WALLACE 1717 RHODE ISLAND AVENUE NW NO 700 WASHINGTON DC 20036 1431474 0 X WWW.ABC2.ORG X 2001 DC ACCELERATE BRAIN CANCER CURE HAS A SINGLE FOCUS-TO HASTEN THE DISCOVERY OF A CURE FOR BRAIN CANCER. X 8 8 6 300 0 0 1912674 1410344 0 0 2681 10019 0 -253652 1915355 1166711 363475 2499437 0 0 850117 1152879 0 0 659418 370692 333783 1584284 3986099 331071 -2819388 3099618 0 280230 0 2819388 0 TO ACCELERATE PROGRESS IN WHAT HAS BEEN AN UNDERSERVED FIELD OF RESEARCH; THE ORGANIZATION AIMS TO RAISE AWARENESS ABOUT BRAIN CANCER AND HELP MOBILIZE CRITICAL SCIENTIFIC RESEARCH THROUGH RESEARCH GRANTS. 0 0 2874312 2499437 ACCELERATE BRAIN CANCER CURE, INC. (ABC2) BELIEVES A FOCUSED AND AGGRESSIVE ENTREPRENEURIAL MODEL WILL INCREASE THE NUMBER OF THERAPIES DISCOVERED AND ENABLE THOSE THERAPIES TO BE AVAILABLE TO DOCTORS AND PATIENTS MORE QUICKLY. ABC2 PROVIDES RESEARCHERS WITH THE PIVOTAL SUPPORT THEY NEED TO MAKE CRITICAL BREAKTHROUGHS. IT FUNDS TRANSLATIONAL RESEARCH AIMED AT FINDING THE FASTEST POSSIBLE ROUTE TO A CURE. ABC2 SUPPORTS A RANGE OF MEDICAL RESEARCH ORGANIZATIONS. 2874312 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 1 15 0 1 6 1 0 0 0 0 0 0 0 0 0 0 0 0 X 8 8 1 0 0 0 0 0 0 1 1 0 0 0 1 1 1 1 1 0 0 0 CA NY X MAX WALLACE 2024193140 1717 RHODE ISLAND AVENUE NW NO 700 WASHINGTON DC 20036 STEVE CASE CHAIRMAN & CO-FOUNDER 1.00 X X 0 0 0 STACEY CASE CO-FOUNDER 1.00 X 0 0 0 NANCY PFUND MEMBER 1.00 X 0 0 0 DAVID COLE MEMBER 1.00 X 0 0 0 JEAN CASE CO-FOUNDER 1.00 X 0 0 0 DOUG HOLLADAY MEMBER 1.00 X 0 0 0 JONATHAN WEINBERG MEMBER 1.00 X 0 0 0 GARY WIMMER MEMBER 1.00 X 0 0 0 MAX WALLACE PRESIDENT AND CEO 40.00 X 536539 0 16338 DAVID SANDAK VP/SECRETARY/TREASURER 40.00 X 318748 0 12864 855287 0 29202 2 0 1 0 0 1059338 351006 1410344 21130 21130 11111 -11111 -11111 -11111 0 1059338 253652 -253652 -253652 1166711 0 0 -243633 2499437 2499437 884489 196436 274467 413586 208375 47198 64708 96469 4857 945 1335 2577 7300 348 2310 4642 47858 9500 15185 23173 12761 12761 58300 58300 139276 38491 1034 99751 14725 3420 8915 2390 7269 583 6686 17889 3600 10689 3600 29597 27965 1632 10970 10633 317 20 38104 36339 1765 LICENSE AND REGISTRATIO 4892 4892 3986099 2874312 452369 659418 38013 0 2878185 0 163206 0 513 0 0 0 0 0 6909 0 0 0 11112 0 0 0 0 0 1680 0 3099618 0 129415 0 100000 0 50815 0 280230 0 X 2618169 0 201219 0 2819388 0 3099618 0 -2819388 0 X 0 0 0 X 2575366 1961022 1772747 1912674 1410334 9632143 2575366 1961022 1772747 1912674 1410334 9632143 643900 8988243 2017 1732 6629 5406 21130 36914 9669057 0.92960 0.93420 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RACE FOR HOPE 914119 914119 114243 FLORIDA BRAIN CANCER WALK 112894 112894 25009 4 32325 32325 114400 1059338 1059338 253652 253652 -253652 1 UNC LINEBERGER COMPREHENSIVE CANCER CENTER CAMPUS BOX 7295 CHAPEL HILL NC 27599 566057494 501(C)(3) 5000 TO SUPPORT A CANCER RELATED SYMPOSIUM JOHNS HOPKINS UNIVERSITY - MONTGOMERY 9601 MEDICAL CENTER DR ROCKVILLE MD 20850 520595110 501(C)(3) 6796 PATENTS UNC-CHAPEL HILL SCHOOL OF MEDICINE 20 DUKE MEDICINE CIR DURHAM NC 27710 566057494 501(C)(3) 169292 TO SUPPORT THE PROJECT TITLED "DEVELOPING TUMOR-HOMING STEM CELL BEACONS FOR IMMUNE-BASED CANCER THERAPY." UPLIFTING ATHLETES INC 8 ATKINSON DRIVE DOYLESTOWN PA 18901 341986485 501(C)(3) 10000 FOR BRAIN CANCER RESEARCH TO DR. EUGENE HWANG AT CHILDREN'S NATIONAL MEDICAL CENTER IN DC. THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 710 WESTWOOD PLAZA LOS ANGELES CA 90024 943067788 501(C)(3) 116523 TO SUPPORT THE EVALUATION OF ALTERNATIVE IMAGING ENDPOINTS FOR MIDLINE GLIOMAS. BROAD INSTITUTE INC 415 MAIN STREET CAMBRIDGE MA 02142 263428781 501(C)(3) 156726 GBM CASES FOR CLIA SOMTIC WES - 2017 TEMPUS INC 29280 NETWORK PLACE CHICAGO IL 60673 474903308 N/A 97200 RESEARCH SEQUENCING DANA-FARBER CANCER INSTITUTE 450 BROOKLINE AVE BOSTON MA 02215 042263040 501(C)(3) 56865 TO SUPPORT A PROGRAM THAT PROVIDES ROBUST CLINICAL GENOMIC PROFILING FOR BRAIN CANCER PATIENTS. BENIZOLE THERAPEUTICS PBC 1117 BERNOUDY ROAD WHITE HALL MD 21161 000000000 N/A 20000 TO COVER THE COST OF A REGULATORY CONSULTANT TO HELP PLAN A PHASE II TRIAL. NATIONAL BRAIN TUMOR SOCIETY 55 CHAPEL ST STE 200 NEWTON MA 02458 043068130 501(C)(3) 1861035 TO PROMOTE BRAIN CANCER RESEARCH. 8 2 PART I, LINE 2: ABC2 CLOSELY MONITORS THE PROGRESS OF THE RESEARCHERS IT FUNDS THROUGH ITS GRANT PROGRAM. THE ORGANIZATION REQUIRES SCIENTIFIC PROGRESS REPORTS AND COMPLETE FINANCIAL ACCOUNTING OF EXPENDITURES BEFORE RELEASING ADDITIONAL FUNDS AS WELL AS FINAL GRANT REPORTS INCLUDING FINANCIAL REPORTS. IN ADDITION, ABC2 HOLDS AN ANNUAL SCIENTIFIC MEETING AT WHICH TIME CERTAIN GRANTEES PRESENT THEIR PROGRESS. X X 0 0 0 0 0 0 0 0 0 MAX WALLACE PRESIDENT AND CEO 536539 0 0 0 0 0 0 0 16338 0 552877 0 0 0 DAVID SANDAK VP/SECRETARY/TREASURER 318748 0 0 0 0 0 8955 0 3909 0 331612 0 0 0 CASH DONATION 2019-12-30 1861035 043068130 NATIONAL BRAIN TUMOR SOCIETY 55 CHAPEL ST STE 200 NEWTON MA 02458 501(C)(3) 0 0 0 0 1 0 0 0 0 FORM 990, PART VI, SECTION A, LINE 2 STEPHEN CASE, CHAIRMAN & BOARD MEMBER AND JEAN CASE, BOARD MEMBER ARE CO-FOUNDERS AND SPOUSES. STACEY CASE, BOARD MEMBER AND CO-FOUNDER, IS THE SISTER-IN-LAW OF STEPHEN CASE. THESE BOARD MEMBERS ALSO HAVE BUSINESS RELATIONSHIPS. FORM 990, PART VI, SECTION B, LINE 11B MAX WALLACE, THE CHIEF EXECUTIVE OFFICER OF ACCELERATE BRAIN CANCER CURE, INC. REVIEWS AND SIGNS THE 990. THE 990 IS ALSO REVIEWED BY THE FINANCE COMMITTEE BEFORE IT IS FILED. FORM 990, PART VI, SECTION B, LINE 12C THE BOARD OF DIRECTORS REVIEWS THE CONFLICT OF INTEREST POLICY AT ITS ANNUAL BOARD MEETING. INDEPENDENCE IS ALSO CONFIRMED PRIOR TO THE AWARDING OF ANY EXPENDITURE RESPONSIBILITY GRANT. FORM 990, PART VI, SECTION B, LINE 15 THE CHIEF EXECUTIVE OFFICER JOINED THE ORGANIZATION IN 2008. AS PART OF THE EXECUTIVE SEARCH PROCESS AN INDEPENDENT SEARCH FIRM PERFORMED AN INDUSTRY COMPENSATION ANALYSIS. THE LAST COMPENSATION REVIEW TOOK PLACE ON DECEMBER 2015. THE ORGANIZATION HAD NO KEY EMPLOYEES. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANICAL STATEMENTS AVAILABLE FOR PUBLIC INSPECTION UPON REQUEST.